Financials

  • Market Capitalization 1.74 B
  • Employee 140
  • Founded 2011
  • CEO N/A
  • Website www.absci.com
  • Headquarter Washington, United States
  • FIGI BBG011N54CJ8
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.15
ratio cours/chiffre d'affaires
170.48

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2037
ZBIO
Zenas BioPharma, Inc. - Common Stock
27.26 USD+3.89%-4.25%-12.06%+3.02%1.78 B USD
2046
NUVB
Nuvation Bio Inc. Class A Common Stock
5.00 USD+0.40%-1.96%-15.25%+31.93%1.76 B USD
2083
OCUL
Ocular Therapeutix, Inc. - Common Stock
7.54 USD+0.40%+8.80%-28.93%-34.43%1.66 B USD
2108
STOK
Stoke Therapeutics, Inc. - Common Stock
24.74 USD+3.30%-4.18%-15.79%-18.03%1.60 B USD

Nouvelles